Correlation Between VBI Vaccines and Akero Therapeutics

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both VBI Vaccines and Akero Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining VBI Vaccines and Akero Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between VBI Vaccines and Akero Therapeutics, you can compare the effects of market volatilities on VBI Vaccines and Akero Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in VBI Vaccines with a short position of Akero Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of VBI Vaccines and Akero Therapeutics.

Diversification Opportunities for VBI Vaccines and Akero Therapeutics

-0.22
  Correlation Coefficient

Very good diversification

The 3 months correlation between VBI and Akero is -0.22. Overlapping area represents the amount of risk that can be diversified away by holding VBI Vaccines and Akero Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Akero Therapeutics and VBI Vaccines is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on VBI Vaccines are associated (or correlated) with Akero Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Akero Therapeutics has no effect on the direction of VBI Vaccines i.e., VBI Vaccines and Akero Therapeutics go up and down completely randomly.

Pair Corralation between VBI Vaccines and Akero Therapeutics

If you would invest  2,675  in Akero Therapeutics on September 5, 2024 and sell it today you would earn a total of  417.00  from holding Akero Therapeutics or generate 15.59% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy0.0%
ValuesDaily Returns

VBI Vaccines  vs.  Akero Therapeutics

 Performance 
       Timeline  
VBI Vaccines 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days VBI Vaccines has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of fairly stable forward indicators, VBI Vaccines is not utilizing all of its potentials. The current stock price fuss, may contribute to near-short-term losses for the sophisticated investors.
Akero Therapeutics 

Risk-Adjusted Performance

7 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in Akero Therapeutics are ranked lower than 7 (%) of all global equities and portfolios over the last 90 days. In spite of very unfluctuating basic indicators, Akero Therapeutics displayed solid returns over the last few months and may actually be approaching a breakup point.

VBI Vaccines and Akero Therapeutics Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with VBI Vaccines and Akero Therapeutics

The main advantage of trading using opposite VBI Vaccines and Akero Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if VBI Vaccines position performs unexpectedly, Akero Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Akero Therapeutics will offset losses from the drop in Akero Therapeutics' long position.
The idea behind VBI Vaccines and Akero Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Idea Optimizer module to use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio .

Other Complementary Tools

Portfolio Backtesting
Avoid under-diversification and over-optimization by backtesting your portfolios
AI Portfolio Architect
Use AI to generate optimal portfolios and find profitable investment opportunities
Portfolio Comparator
Compare the composition, asset allocations and performance of any two portfolios in your account
Price Ceiling Movement
Calculate and plot Price Ceiling Movement for different equity instruments
Aroon Oscillator
Analyze current equity momentum using Aroon Oscillator and other momentum ratios